---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-028094"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2022-11-28T23:59:59+00:00"
generated_at: "2026-06-21T12:33:28.298264+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma stockholders re-elect Eric Friedman as Class III director, ratify Marcum LLP as auditor

## Summary
- Eric Friedman elected as Class III director for term until 2025 Annual Meeting; vote: 21.7M for, 85.9K withheld, 1.6M broker non-votes.
- Ratification of Marcum LLP as independent auditor for FY ending June 30, 2023 approved: 23.4M for, 25.8K against, 30K abstain.
- Quorum of 23.5M shares out of 29.9M outstanding shares present at November 28, 2022 Annual Meeting.
- No other matters were voted upon at the meeting.

## SEC filing metadata
- accession: 0001437749-22-028094
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2022-11-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/0001437749-22-028094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/inbp20221128_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-028094
- JSON: https://secwatch.observer/filing/0001437749-22-028094.json
- Plain text: https://secwatch.observer/filing/0001437749-22-028094.txt

## Key facts
- Shareholder Votes
  INTEGRATED BIOPHARMA INC shareholders approved Ratification of appointment of Marcum LLP as independent auditors for the fiscal year ending June 30, 2023 at the 2022-11-28 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-11-28
  source text: Proposal No. 2 – To ratify the appointment of the Company ’ s independent auditors for the fiscal year ending June 30, 2023 The Company’s stockholders voted in favor of ratifying the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending June 30, 2023. The final voting results were as follows: For Against Abstain 23,403,076 25,801 30,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/0001437749-22-028094-index.htm
- Shareholder Votes
  INTEGRATED BIOPHARMA INC shareholders approved Election of one Class III director for a three-year term to serve until the 2025 Annual Meeting of Stockholders at the 2022-11-28 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-11-28
  source text: Proposal No. 1 – To elect one Class III director for a three-year term to serve until the 2025 Annual Meeting of Stockholders The Company’s stockholders voted for the election of one Class III director, Eric Friedman, to serve until the 2025 Annual Meeting of Stockholders (subject to his respective earlier removal, death or resignation) and until his successor is elected and qualified. The final voting results were as follows: Broker For Withheld Non-Votes Eric Friedman 21,738,259 85,901 1,634,717
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/0001437749-22-028094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.